We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Results 1 to 5 of 36
Most popular |Most recent

Supreme Court Expands Application of Exemption for Business Data Under FOIA

USA - June 26 2019 Rejecting a standard that had governed lower courts for 45 years, the U.S. Supreme Court has made it easier for federal agencies to protect...

Eric M. Stahl, Chip English, Ashley L. (Watkins) Vulin, Ronald G. London.

Takeaways from FDA’s Public Hearing on Cannabis and Cannabis-Derived Compounds

USA - June 6 2019 The U.S. Food and Drug Administration’s (“FDA”) May 31 public hearing on cannabis and cannabis-derived compounds (including hemp-derived CBD)...

Chip English, Jeffrey Giametta.

TTB Aligns with FDA on Use of Hemp-Derived CBD

USA - May 14 2019 The Alcohol and Tobacco Tax and Trade Bureau (“TTB”) recently issued updated guidance on the addition of hemp-derived CBD to alcohol beverages. In...

FDA Sets First Cannabis Hearing for May 31

USA - April 3 2019 The FDA announced it will host its first public hearing on cannabis and cannabis-derived compounds (including hemp-derived CBD) on May 31, 2019 in...

Congress Passes Farm Bill, Pushing Toward Full “Legalization” of Hemp and Hemp-Derived CBD

USA - January 7 2019 On December 20, 2018, President Trump signed H.R. 2, the Agriculture Improvement Act of 2018 (“2018 Farm Bill”). Among other things, the 2018 Farm...

Jeffrey Giametta.